Professional Documents
Culture Documents
13 Malaria
13 Malaria
Cerebral malaria is manifested by delirium, seizures or coma, usually without localising signs.
Immunity is impaired in pregnancy and the parasite can preferentially bind to the placental
protein chondroitin sulphate A. Abortion and IUGR from parasitisation of the maternal side of
.the placenta are frequent. Previous splenectomy increases the risk of severe malaria
P. vivax and P. ovale infection
In many cases, the illness starts with several days of continued fever before the development of classical
bouts of fever on alternate days. Fever starts with a rigor, temperature rises to about 40°C. After half an
hour to an hour, the hot or flush phase begins. It lasts several hours and gives way to profuse perspiration
and a gradual fall in temperature. The cycle is repeated 48 hours later. Gradually, the spleen and liver
enlarge and may become tender. Anaemia develops slowly. Relapses are frequent in the first 2 years after
. .leaving the malarious area and infection may be acquired from BTx
• Immunochromatographic rapid diagnostic tests (RDTs) for malaria antigens, are extremely sensitive
and specific for falciparum but less so for other species. They should be used in parallel with blood
film examination but are especially useful where the microscopist is less experienced in examining
blood films . They are less sensitive for low-level parasitaemia and positivity may persist for a month
or more in some individuals.
• DNA detection (PCR) determine whether a patient has a recrudescence of the same malaria parasite
or a reinfection with a new parasite.
Management
Mild malaria
Preferred therapy
Co-artemether (artemether +lumefantrine) •
Alternative therapy
Quinine, together with or followed by doxycycline •
Malarone (Atovaquone+proguanil) •
Pregnancy
.Co-artemether but avoid in early pregnancy •
Quinine plus clindamycin •
Other regimens
Artesunate and mefloquine •
Severe malaria
Preferred therapy
Artesunate •
Alternative therapy
Quinine, Combine with doxycycline (or clindamycin if there are contraindications to doxycycline) •
Non-falciparum malaria
Preferred therapy
Chloroquine: plus primaquine after confirming G6PD-negative Patient •
Co-artemether •
Patients with mild to moderate G6PD deficiency and P. vivax or P. ovale
Chloroquine plus primaquine •
Chloroquine-resistant P. vivax
Co-artemether as for P. falciparum •
Chemoprophylaxis of malaria
Chloroquine resistance high
Mefloquine weekly Started 2–3 weeks before travel and continued until 4 weeks after
or Doxycycline daily Started 1 week before and continued until 4 weeks after travel
or Malarone 1 tablet daily From 1–2 days before travel until 1 week after return